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Introduction 
Endothelins are a family of potent vasoconstrictor peptides originally isolated from porcine 
aortic endothelial cells (26). They have subsequently been found to be produced by a number 
of other cell types including epithelial cells, certain populations of neurons, and glial cells 
(1,4,12,18). Since their identification in monocytes/macrophages and mast cells, they have 
been considered to be cytokines (3,6). The regulation of endothelin secretion differs conside-
rably among cell types. This different regulation seems to represent important aspects of 
endothelin biology. Thus, auto-/paracrine mechanisms apparently play a major role in the 
activity of these peptides (5,13). Monocytes and mast cells respond to environmental Stimuli 
like bacterial lipopolysaccharide or antigen-triggered IgE with an increase in endothelin 
secretion (3,6). Other cell types, e.g. smooth muscle cells or glial cells, can be induced in 
an autostimulatory fashion to potentiate their endothelin production (5,13). This autoregula-
tory amplification can lead to high local levels of these peptides, as has been shown for 
instance in lung tissue of patients suffering from allergic asthma (22). These flndings are of 
particular relevance with respect to the extremely potent and long lasting smooth muscle 
constricting properties of these peptides as well as to their mitogenic actions in various cell 
types (23,24). 
Invasion of the brain by monocytes/macrophages and subsequent formation of multinu-
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cleated giant cells as well as astrocytic gliosis are prominent features of HIV-1 encephalopat-
hy (14,15,16,20). Clinical and pathological observations pointing to an involvement of 
cerebral blood vessels in this condition (8,17,19) are for example: fluctuating neuropsychia-
tric Symptoms, abnormal findings in Single photon emission computed tomography (SPECT) 
and positron emission tomography (PET) analyses even in asymptomatic HlV-seropositive 
individuals, thickening of medium sized and small vessels, vascular calcifications, particular-
ly in children with AIDS, a relatively high incidence of unexplained transient ischemic 
attacks and cerebral infarctions, reversibility of neurological Symptoms upon AZT-treatment 
in some patients, and, finally, cerebral atrophy similar to the one observed in multiinfarct 
dementia (14,15,20). We hypothesize that macrophage-derived endotheiins, by virtue of their 
potent vasoconstricting activities that can affect cerebral blood vessels of all sizes and types 
(27), might cause these primarily functional vascular disturbances. 
In an attempt to elucidate the role of endotheiins in HIV-1 encephalopathy, different 
experimental approaches were chosen. Using immunohistochemistry, we investigated brain 
sections of HIV-1 infected individuals for the presence and distribution of endothelin imm-
unoreactivity. In order to extend this study to a larger number of patients and to assess 
whether histological findings with endotheiins might be reflected by cerebrospinal fluid 
levels of these peptides, we measured the endothelin-1 concentrations together with other 
indicators of macrophage activation in the cerebrospinal fluid of HIV-1 infected patients at 
different disease stages. As vascular involvement in general seems to be a frequent phenome-
non in HIV-1 infection, we further determined endothelin-1 concentrations in the plasma of 
HIV-1 infected patients with and without clinical evidence of microcirculatory dysfunction. 
Immunohistochemistry of Brain Sections 
Brain tissue was obtained upon autopsy from three HIV-1 infected patients. Autopsy was 
performed within 24 hours. All patients had clinical evidence of HIV-1 encephalopathy. 
Other reasons for neurological dysfunction were widely excluded; especially, indication of 
opportunistic infections or malignancies of the central nervous System was not present. 
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Paraffin sections of the frontal lobe were incubated with an antiserum against endothelin-1 
(Peninsula Laboratories, Belmont, California, USA) and processed for second antibody-
immunoperoxidase staining. Cell nuclei were counterstained with hematoxylin. A representa-
tive brain section is shown in Fig. 1. A large number of cells stained distinctly positive for 
endothelin-1. These cells were identified as macrophages by staining consecutive sections for 
CD68, a macrophage-specific marker (not shown). Macrophages were not present in the 
cerebral tissue of healthy controls. Moreover, in HIV-1 infected individuals there was a 
much higher percentage of cerebral microvessel endothelial cells displaying endothelin 
immunoreactivity as compared to normal brain. 
Figure 1: Macrophages and microvascular endothelial cells in the brain of patients with HIV-1 encephalopathy 
stain positively for endotheiins. Frontal lobe tissue was obtained upon autopsy from a patient with HIV-1 
encephalopathy without indications of opportunistic infections of the central nervous System. Paraffin sections 
were processed for immunoperoxidase staining using an antiserum specific for endothelin-1. Cell nuclei were 
counterstained with hematoxylin. Consecutive sections, stained for CD68, a macrophage*specific marker, 
identified endothelin positive cells as macrophages (not shown). 
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Macrophage-Activation Markers and Endothelin in Cerebrospinal Fluid 
of HIV-1 Infected Patients 
In order to assess whether the histological findings of endothelin immunoreactive macropha-
ges in the brain of HIV-1 infected patients might be reflected by altered levels of these 
peptides in an accessible compartment of the brain, we measured immunoreactive endo-
thelin-1 in the cerebrospinal fluid of HIV-1 infected patients at different disease stages as 
well as in healthy controls. In addition, the assays of neopterin and /32-microglobulin, 
established markers of macrophage activation, were determined to correlate endothelin levels 
with macrophage activation. 
The normal ränge of the three parameters under our assay conditions was established 
using cerebrospinal fluid obtained from 10 neurologically healthy patients undergoing spinal 
anaesthesia for a variety of reasons. A total of 114 HIV-1 infected patients were investiga-
ted. Staging was performed according to the Walter Reed (WR) Classification System. Nine 
patients were in WR1, 15 in WR2, 10 in WR3, 12 in WR4, 22 in WR5, and 46 in WR6. 
Cerebrospinal fluid was obtained from the patients undergoing lumbar puncture for diagno-
stic purposes after informed consent. Neopterin was measured by a radioimmunoassay 
(Henning, Berlin, Germany) and j92-microglobulin by an enzyme-linked-immuno-sorbent— 
assay (Behring, Marburg, Germany). The assay for endothelin consisted of a simultaneous 
sample clean-up and concentration step on C18-extraction cartridges according to (7), 
followed by a radioimmunoassay (Amersham, Braunschweig, Germany). For endothelin 
determination, as much as 2.0 ml of CSF is usually needed to give reproducible results. 
Therore, endothelin levels could not be analysed in all patients. 
The macrophage activation markers neopterin and ß2-microglobulin were significantly 
elevated in HIV-1-infected patients as compared to controls (2). This was true for all disease 
stages. Interestingly, we noted a biphasic curve with a smaller peak in WR2 and a large 
increase in WR6 (Fig.2). A similar biphasic pattern with disease progression was observed 
for endothelin-1. The endothelin-1 elevation in the early WR stages was not significant as 
compared to controls. In WR 5 and 6, however, endothelin-1 levels exceeded the normal 
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ränge significantly. The kinetics of cerebrospinal fluid endothelin levels during disease 
progression, which parallel those obtained for neopterin and /32-microglobulin, suggest a 
close correlation between the degree of activation of cerebral macrophages and endothelin 
concentrations in cerebrospinal fluid of HIV-1 patients. 
4.5 -| 5 5 - , 
CONTROLS WR1 WR2 WR3 WR4 WR5 WR6 
Figure 2: Endothelin, neopterin and b2-microglobulin increase in a biphasic pattern with disease progression 
in cerebrospinal fluid of HIV-1 infected patients. Values represent mean ± Standard deviation of a total of 114 
patients. Distribution in Walter Reed (WR) stages is mentioned in the text. The respective scales as well as the 
respective normal values are indicated on the left and right side. 
Plasma Endothelin Concentration and Vascular Disease in HIV-1 Infection 
Microangiopathy of the retina comparable to that seen in diabetes mellitus or other vascular 
disorders is a phenomenon also encountered in HIV-1 infection. These ocular circulatory 
deficiencies are often accompanied by an impairment of cerebral perfusion as assessed by 
HMPAO-SPECT (technetium-99m-hexamethyl-propyleneamine oxime Single photon emission 
computed tomography of the brain) (11). To elucidate a possible role of endotheiins in these 
functional vascular disturbances, we measured endothelin-1 concentrations in the plasma of 
HIV-1 infected patients. A total of 63 subjects was investigated, 13 in WR 1 and 2, 13 in 
WR 3 and 4, and 37 in WR 5 and 6. Eight out of the 63 patients had Kaposi sarcoma and 
11 had HIV-1 related neurological dysfunction (AIDS dementia complex), but no evidence 
152 Goebel et al.: Endotheiins in HIV-1 infection 
of opportunistic infections of the central nervous System. Thirty-seven out of the 63 patients 
could be investigated by fundoscopy. Fourteen of these 37 subjects had evidence of microan-
giopathy. 
Normal values were established from 13 healthy volunteers. For endothelin determina-
tion in the plasma, the extraction method was modified (Rolinski, in preparation). The radio-
immunoassay used for plasma determinations was obtained from New England Nuclear/ 
Dupont (Dreieich, Germany). The average endothelin-1 concentration in the 63 HIV-1 
infected patients was significantly elevated as compared to controls (3.14 ± 1.27 vs 2.72 ± 
0.67 fmol/ml, p < 0.05). In contrast to the biphasic pattern of endothelin levels observed 
in the cerebrospinal fluid, plasma concentrations displayed a steady increase with disease 
stage - from 2.49 ± 0.68 fmol/ml in WR 1/2 to 3.07 ± 1.38 and 3.61 ± 1.2 fmol/ml in 
WR 3/4 and WR 5/6, respectively (Fig. 3). The difference between WR 1/2 and 5/6 was 
statistically significant (p < 0,01). 
Interestingly, HIV-1 infected patients with funduscopically confirmed microangiopathy 
had significantly higher plasma levels of endothelin-1 as compared to HIV-1 infected patients 
without microangiopathy (4.02 ± 1.05 vs 2.98 ± 0.96 fmol/ml, p < 0.003) or to controls 
(p < 0.001)(Fig.4). Similarily, patients with HIV-1 related neurological dysfunction had 
significantly increased plasma concentrations as compared to all other HIV-1 infected pa-
tients (3.69 ± 1.00 vs 2.99 ± 1 . 1 3 fmol/ml, p < 0.05). In the groups of patients with 
microangiopathy or neurological AIDS there was a higher incidence of advanced disease 
(WR 5 and 6). This fact, however, is unlikely to fully account for the differences found 
since patients with Kaposi sarcoma, all in WR 5 and 6, did not have significantly increased 
endothelin levels as compared to all other HIV-1 infected patients (3.59 ± 0.74 vs 3.15 ± 
1.29 fmol/ml, n.s.). 
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Figure 3: Endothelin concentration in the plasma increases with disease progression. Scattergrams and mean 
value of plasma levels of a total of 63 patients are shown. Values in Walter Reed stages 5 and 6 are significant-
ly higher than those in WR I and 2 (p < 0.01). 
potients without 
microongiopothy 




Figure 4: Endothelin concentration in plasma is elevated in HIV-1 infected patients with ocular microangio-
pathy. Scattergrams and mean values of plasma levels of a total of 37 patients are shown. The difference is 
statistically significant (p < 0.003). 
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Conclusions 
Taken together, our data suggest that cerebral and ocular vascular disease in HIV-1 infection 
might be related to high levels of endotheiins. It is unclear at present whether the enhanced 
levels in cerebrospinal fluid and plasma are caused by an increased production or a reduced 
elimination of endotheiins or by both mechanisms. Nevertheless, the varying pattern of 
endothelin elevation in the plasma and cerebrospinal fluid with disease progression raises 
the questions whether a regulär connection between the two compartments, cerebrospinal 
fluid and plasma, exists with respect to endotheiins in HIV-1 infection. 
Interestingly, recent data from our laboratories show that there is a distinct expression 
of the endothelin-1 gene in monocytes isolated from the peripheral blood of HIV-1 seroposi-
tive individuals which cannot be observed in healthy controls or in patients with multiple 
sclerosis, systemic lupus erythematosus or with common cold. It should be emphasized, 
however, that enhanced transcription of the endothelin-1 gene in these cells most likely 
reflects a general State of monocyte activation which is not specific for HIV-1 infection. 
Nevertheless, monocytic endotheiins in HIV-1 infection may contribute to the observed 
increased plasma levels. In addition, monocytes recruited to the brain may release high 
amounts of endotheiins. In concert with other cytokines such as TNFa and IL-6, which are 
apparently involved in HIV-1 encephalopathy (9,10,21,25), these potent vasoconstrictors are 
likely to amplify functional impairment and tissue damage in this condition. 
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